Docusign is rated Buy with a $81 price target, offering 14% upside potential and market outperformance over the next 12 months. DOCU trades at a 25% discount to sector median P/E, despite exceptional ...
DocuSign posted revenue and earnings growth, beating estimates. The company's free cash flow fell slightly, and its full-year forecast underwhelmed investors. DocuSign has steadied itself, but ...